SKI Market

A+| A| A-|

Indian Indices

Sensex

78,151.45 964.58
( 1.25%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,574.52 2.28
(0.02%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

145.1556811

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

16284.44

EPS(TTM)

Face Value()

Div & Yield %

1.97

0.49

Back

Elitecon International standalone net profit rises 44.11% in the December 2025 quarter

Mar 09,2026

Net profit of Elitecon International rose 44.11% to Rs 9.54 crore in the quarter ended December 2025 as against Rs 6.62 crore during the previous quarter ended December 2024. Sales rose 938.70% to Rs 502.73 crore in the quarter ended December 2025 as against Rs 48.40 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	502.73	48.40	939
OPM %	2.93	13.29	-
PBDT	15.12	7.00	116
PBT	14.60	6.63	120
NP	9.54	6.62	44

78,151.45 964.58 ( 1.25%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,574.52 2.28 (0.02%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)